Parkman Healthcare Partners’s Compass Pathways CMPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Buy
554,411
+454,939
+457% +$3.06M 0.32% 76
2025
Q4
$686K Sell
99,472
-528
-0.5% -$3.22K 0.07% 95
2025
Q3
$573K Buy
+100,000
New +$449K 0.06% 88

Other funds holding CMPS

Parkman Healthcare Partners's CMPS Position: Q1 2026 in Review

Parkman Healthcare Partners increased its Compass Pathways (CMPS) stake by 457% in Q1 2026, buying an estimated $3.06M and bringing the position to 554,411 shares worth $3.07M. The position accounts for 0.32% of the portfolio, ranked #76.

Parkman Healthcare Partners first reported a position in CMPS in Q3 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold CMPS as of Q1 2026.

  • Parkman Healthcare Partners held 554,411 shares of Compass Pathways worth $3.07M as of Q1 2026.
  • Parkman Healthcare Partners bought 454,939 Compass Pathways shares in Q1 2026, an estimated $3.06M.
  • Compass Pathways made up 0.32% of Parkman Healthcare Partners's portfolio in Q1 2026, its #76 holding.
  • Parkman Healthcare Partners first reported a position in Compass Pathways in Q3 2025 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Compass Pathways as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.